Owner Albert Einstein College of Medicine of Yeshiva University

Inventors Lawrence, David S; Zhang, Zhong-Yin

Agent Shelston IP

Pub. Number AU-B-2002363632

PCT Number PCT/US02/30492

PCT Pub. Number WO2003/041729

Priority 60/325,009 26.09.01 US

Filing date 26 September 2002

Wipo publication date 26 May 2003

Acceptance publication date 24 May 2007

C12N 9/99 (2006.01) Enzymes, e.g. ligases (6.) - Enzyme inactivation by chemical treatment

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07F 9/38 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07K 5/02 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C12Q 1/42 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving phosphatase

G01N 33/573 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for enzymes or isoenzymes